Dianhydrogalactitol (VAL-083) in combination with AZD1775 increases survival in diffuse intrinsic pontine glioma (DIPG), in vivo

被引：0
|
作者：
Steino, Anne [1 ]
Yang, Xiaodong [2 ]
Kline, Cassie [2 ]
Bacha, Jeffrey [1 ]
Brown, Dennis M. [3 ]
Mueller, Sabine [2 ]
机构：
[1] Delmar Pharmaceut Inc, Vancouver, BC, Canada
[2] Univ Calif San Francisco, San Francisco, CA 94143 USA
[3] Delmar Pharmaceut Inc, Menlo Pk, CA USA
来源：
CANCER RESEARCH | 2019年 / 79卷 / 13期
关键词：
D O I：
10.1158/1538-7445.SABCS18-3499
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3499
引用
收藏
页数：2
相关论文
共 38 条
  • [31] H3.3 K27M depletion increases differentiation and extends latency of diffuse intrinsic pontine glioma growth in vivo
    André B. Silveira
    Lawryn H. Kasper
    Yiping Fan
    Hongjian Jin
    Gang Wu
    Timothy I. Shaw
    Xiaoyan Zhu
    Jon D. Larson
    John Easton
    Ying Shao
    Donald A. Yergeau
    Celeste Rosencrance
    Kristy Boggs
    Michael C. Rusch
    Liang Ding
    Junyuan Zhang
    David Finkelstein
    Rachel M. Noyes
    Brent L. Russell
    Beisi Xu
    Alberto Broniscer
    Cynthia Wetmore
    Stanley B. Pounds
    David W. Ellison
    Jinghui Zhang
    Suzanne J. Baker
    Acta Neuropathologica, 2019, 137 : 637 - 655
  • [32] PHASE 1 TRIAL OF WEE1 KINASE INHIBITOR AZD1775 COMBINED WITH RADIATION THERAPY FOR CHILDREN WITH NEWLY DIAGNOSED DIFFUSE INTRINSIC PONTINE GLIOMA: A REPORT FROM THE CHILDREN'S ONCOLOGY GROUP PHASE 1 PILOT CONSORTIUM (ADVL1217)
    Mueller, Sabine
    Yang, Xiaodong
    Pal, Sharmistha
    Ermioian, Ralph
    Fox, Elizabeth
    Gajjar, Amar
    Minard, Charles
    Liu, Xiaowei
    Prem, Komal
    Reid, Joel
    Weigel, Brenda
    Haas-Kogan, Daphne
    NEURO-ONCOLOGY, 2018, 20 : 201 - 201
  • [33] PHASE 1 TRIAL OF WEE1 KINASE INHIBITOR ADAVOSERTIB (AZD1775) COMBINED WITH RADIATION THERAPY FOR CHILDREN WITH NEWLY DIAGNOSED DIFFUSE INTRINSIC PONTINE GLIOMA: A REPORT FROM THE CHILDREN'S ONCOLOGY GROUP PHASE 1 PILOT CONSORTIUM (ADVL1217)
    Mueller, Sabine
    Yang, Xiaodong
    Pal, Sharmistha
    Ermoian, Ralph
    Gajjar, Amar
    Liu, Xiaowei
    Prem, Komal
    Minard, Charles G.
    Mugundu, Ganesh
    Reid, Joel M.
    Haas-Kogan, Daphne
    Fox, Elizabeth
    Weigel, Brenda J.
    NEURO-ONCOLOGY, 2018, 20 : 284 - 284
  • [34] Correction to: H3.3 K27M depletion increases differentiation and extends latency of diffuse intrinsic pontine glioma growth in vivo
    André B. Silveira
    Lawryn H. Kasper
    Yiping Fan
    Hongjian Jin
    Gang Wu
    Timothy I. Shaw
    Xiaoyan Zhu
    Jon D. Larson
    John Easton
    Ying Shao
    Donald A. Yergeau
    Celeste Rosencrance
    Kristy Boggs
    Michael C. Rusch
    Liang Ding
    Junyuan Zhang
    David Finkelstein
    Rachel M. Noyes
    Brent L. Russell
    Beisi Xu
    Alberto Broniscer
    Cynthia Wetmore
    Stanley B. Pounds
    David W. Ellison
    Jinghui Zhang
    Suzanne J. Baker
    Acta Neuropathologica, 2019, 137 : 1021 - 1021
  • [35] SAFETY, EFFICACY, AND SURVIVAL RESULTS FROM A PHASE 1 STUDY OF THE ONCOLYTIC ADENOVIRUS DNX-2401 FOLLOWED BY STANDARD OF CARE RADIOTHERAPY FOR NEWLY DIAGNOSED DIFFUSE INTRINSIC PONTINE GLIOMA (DIPG)
    Gallego Perez-Larraya, Jaime
    Garcia-Moure, Marc
    Patino-Garcia, Ana
    Gonzalez-Huarriz, Marisol
    Van der Lugt, Jasper
    Astigarraga, Itziar
    Garcia-Ariza, Miguel
    Lopez-Ibor, Blanca
    Jones, Chris
    Mackay, Alan
    Diez-Valle, Ricardo
    Fueyo, Juan
    Gomez-Manzano, Candelaria
    Dobbs, Jessica
    Ewald, Brett
    Alonso, Marta
    Tejada, Sonia
    NEURO-ONCOLOGY, 2021, 23 : 50 - 51
  • [36] H3.3 K27M depletion increases differentiation and extends latency of diffuse intrinsic pontine glioma growth in vivo (vol 137, pg 637, 2019)
    Silveira, Andre B.
    Kasper, Lawryn H.
    Fan, Yiping
    Jin, Hongjian
    Wu, Gang
    Shaw, Timothy I.
    Zhu, Xiaoyan
    Larson, Jon D.
    Easton, John
    Shao, Ying
    Yergeau, Donald A.
    Rosencrance, Celeste
    Boggs, Kristy
    Rusch, Michael C.
    Ding, Liang
    Zhang, Junyuan
    Finkelstein, David
    Noyes, Rachel M.
    Russell, Brent L.
    Xu, Beisi
    Broniscer, Alberto
    Wetmore, Cynthia
    Pounds, Stanley B.
    Ellison, David W.
    Zhang, Jinghui
    Baker, Suzanne J.
    ACTA NEUROPATHOLOGICA, 2019, 137 (06) : 1021 - 1021
  • [37] LONG-TERM SURVIVAL FROM A PHASE 1 DOSE-ESCALATION TRIAL USING CONVECTION-ENHANCED DELIVERY (CED) OF RADIOIMMUNOTHERAPEUTIC 124I-OMBURTAMAB FOR TREATMENT OF DIFFUSE INTRINSIC PONTINE GLIOMA (DIPG)
    Souweidane, Mark M.
    Kramer, Kim
    Pandit-Tasker, Neeta
    Haque, Sofia
    Zanzonico, Pat
    Carrasquillo, Jorge
    Lyashchenko, Serge K.
    Thakur, Sunitha B.
    Khakoo, Yasmin
    Dunkel, Ira J.
    Donzelli, Maria
    Lewis, Jason S.
    Cheung, Nai-Kong V.
    Larson, Steve M.
    Reiner, Anne S.
    Panageas, Katherine S.
    Manino, Nicole
    Nielsen, John Romer
    NEURO-ONCOLOGY, 2022, 24 : 30 - 31
  • [38] Biological medicines for diffuse intrinsic pontine glioma (DIPG) eradication (BIOMEDE): Final results of an international randomized phase II platform trial comparing 3 targeted therapies in combination with radiotherapy from ITCC, SIOPE-Brain and ANZCHOG
    Grill, Jacques
    Le Teuff, Gwenael
    Varlet, Pascale
    Hargrave, Darren R.
    Nysom, Karsten
    Blomgrenn, Klas
    McCowage, Geoffrey Brian
    Bautista, Francisco
    Van Vuurden, Dannis
    Debily, Marie-Anne
    Kergrohen, Thomas
    Puget, Stephanie
    Bolle, Stephanie
    Abbou, Samuel
    Leblond, Pierre
    Boddaert, Nathalie
    Vassal, Gilles
    Le Deley, Marie-Cecile
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
1234